Daily as of 3 Nov 16:00 ET
- Price
- above both $313.52 vs 50 $297.47 / 200 $253.81
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Jul 2025 · projected 29 bars out
LGND | Ligand PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$313.52
+$6.50 (+2.12%)
Ligand Pharmaceuticals (LGND) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Jul 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $322.75 vs 50 $242.86 / 200 $132.89
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 20 Jan 2025 · projected 27 bars out · tested 1 bar
4-hour as of 3 Nov 16:00 ET
- Price
- above both $313.52 vs 50 $305.82 / 200 $295.77
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 13 Mar 2026 · projected 25 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 13 Mar 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
| 23 Feb 2026 | 💀Death | 4-hour | 21 bars out | 4 bar cross test |
| 18 Jul 2025 | 🟨Golden moderate | daily | 29 bars out | Not tested |
| 30 Jun 2025 | 🟨Golden | 4-hour | 26 bars out | — |
| 30 Apr 2025 | 💀Death flat | daily | 20 bars out | 5 bar cross test |
About LGND
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$62.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmid